title: De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine a sirolimus combination.
authors.affiliation: Division of Immunology and Organ Transplantation, University of Texas-Houston, Houston, Texas 77030, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Langer
authors.forename: C T
authors.initials: CT
authors.lastname: Van Buren
authors.forename: S M
authors.initials: SM
authors.lastname: Katz
authors.forename: B D
authors.initials: BD
authors.lastname: Kahan
mesh_terms: D000208:Acute Disease; D019540:Area Under Curve; D016572:Cyclosporine / Q000009:adverse effects* / Q000493:pharmacokinetics; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D007239:Infections / Q000453:epidemiology; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D011183:Postoperative Complications / Q000139:chemically induced* / Q000145:classification; D012189:Retrospective Studies; D020123:Sirolimus / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D016572:Cyclosporine; D020123:Sirolimus